… central nervous system (CNS). Infant B-ALL/LBL with KMT2A translocations have a unique
gene expression … , and other malignancies that express NK cell markers, such as CD56 [1]. …

… expression of CD19, CD20, CD22 and CD79a and T-cell ALL is known for CD3-positivity
and a variable expression of CD1a, CD2, CD5, CD7, CD56 … Success in treating CNS disease …

… Patient 15 relapsed with CNS disease and very low levels of … Also, in silico analysis predicted
reduced immunogenicity … Transduced T cells were depleted of CD56-positive cells prior to …

… (one each for the central nervous system, thymus, pleural … , while CD33 negativity and CD56
positivity were associated with … Early T-cell precursor acute lymphoblastic leukemia and T/…

… , consolidation, maintenance and central nervous system (CNS) prophylaxis. Patients who …
that MRD ≥0·01% is clinically significant in predicting the outcome of T-ALL (Table IV). These …

… appearance as well as expression of CD4, CD56, and CD15. … (AML) or that of acute
lymphoblastic leukemia (ALL). Only in … contribute to or even predict CNS involvement, Pemmaraju …

… 30), of patients with acute lymphoblastic leukemia in molecular CR (ALL … In addition, CD56
expression has been described to … reliable in predicting survival in acute myeloid leukaemia. …

… increased or showed aberrant marker expression. Maturation profiling of CD33 + CD56 −
granulocytes in the BM was carried using CD16 vs. CD11b expression. Normal CD34+ cells …

… Among lymphoblastic leukemias, CD71 expression is higher in T- … CD56 expression is
seen in monoblasts and myeloblasts but is more often present in acute monoblastic leukemia. …

… marker for leukemic stem cell burden at diagnosis of CML. The leukemia stem cell burden
was subsequently used to predict … The expression of CD56 was confirmed in Article II. The anti-…